Ohki Healthcare Holdings (3417) Fundamentals 2026 — P/E 11.6x, Revenue Analysis | SniperIQ
Ohki Healthcare Holdings (3417) is a JP-listed Healthcare company in Medical - Pharmaceuticals with a market capitalization of ¥15.5B, trading at ¥1135.00 on the JPX. This SniperIQ fundamentals page covers Ohki Healthcare Holdings's valuation (P/E 11.6x, P/B 0.5x), profitability (net margin 0.4%), revenue (¥360.4B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Ohki Healthcare Holdings's market cap?
Ohki Healthcare Holdings (3417) has a market capitalization of approximately ¥15.5B, trading at ¥1135.00 on the JPX. Market cap moves with the live share price.
What is Ohki Healthcare Holdings's P/E ratio?
Ohki Healthcare Holdings's trailing twelve-month P/E ratio is 11.6x, with a price-to-book (P/B) of 0.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Ohki Healthcare Holdings?
Ohki Healthcare Holdings runs a net profit margin of 0.4%, a gross margin of 4.9%, and an operating margin of 0.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Ohki Healthcare Holdings generate?
Ohki Healthcare Holdings reported revenue of ¥360.4B for fiscal year 2025, with net income of ¥1.3B and earnings per share (EPS) of 98.16. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Ohki Healthcare Holdings pay a dividend?
Ohki Healthcare Holdings offers a trailing dividend yield of about 2.6%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Ohki Healthcare Holdings financially healthy?
Ohki Healthcare Holdings carries a debt-to-equity ratio of 0.46x and a current ratio of 1.14x, with a market beta of 0.46. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Ohki Healthcare Holdings a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Ohki Healthcare Holdings (3417) the key facts are: market cap ¥15.5B, P/E 11.6x, revenue ¥360.4B, 52-week range 1047-1472. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Ohki Healthcare Holdings's full fundamentals live
Get Ohki Healthcare Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.